Integral Diagnostics Limited(ITGDF)
USD --+0.00%
Reward58Moderate
Risk54Moderate
📊75%Data
Revenue growing 57% YoY
ITGDF
+0.0 · +0.00%
USD · PINK
Integral Diagnostics Limited | Healthcare
Balanced
Market Cap:372.93M
ℹ️
Reward Rating
58
Moderate
Top 50% (model universe)
75% data coverage
ℹ️
Risk Rating
54
Moderate
Risk Assessment
ℹ️

Educational tool only – Scores are based on historical data and financial metrics for informational purposes. This is not financial advice or a recommendation to buy or sell any security. Always conduct your own research or consult a qualified financial adviser.

ℹ️ Educational tool only · More
Limited data coverage
We don't have enough public data on ITGDF to score it reliably yet — Reward, Risk, Forecasts and Dividends tabs aren't available for this stock. The price chart and basic profile are still shown.
OTC / ADR stock — scores and fundamentals use data tagged in USD by our provider. The issuer may report in a different home currency (e.g. JPY), so treat figures as directional rather than precise.
Not available for limited-coverage stocks
The overview tab requires fundamentals and price history we don't have for this stock. The price chart is the most reliable view we have — try the Chart tab.

Market Performance

Stock returned +10.0% over the past year, broadly in line with market conditions.

What is Integral Diagnostics Limited?

Integral Diagnostics Limited, a healthcare services company, provides diagnostic imaging services to general practitioners, medical specialists, and allied health professionals and their patients in Australia and New Zealand.

ITGDF · Verdict

Solid reward · elevated risk

ITGDF's standout is volatility, while balance sheet remains the main concern.

Based on 88% data coverage

ITGDF · Verdict

What’s working & what to watch

Strengths 1

  • Volatility95/100

    Top decile vs peers

Watchouts 1

  • Balance sheet7/100

    Current ratio 0.68

Model-based scoring. For information only — not financial advice.

What is Integral Diagnostics Limited?

Integral Diagnostics Limited, a healthcare services company, provides diagnostic imaging services to general practitioners, medical specialists, and allied health professionals and their patients in Australia and New Zealand. The company offers magnetic resonance imaging, positron emission tomography, computed tomography mammography, interventional radiology, ultrasound, and radiography, such as x-ray and EOS. The company is listed on the PINK in USA, operating in the Healthcare sector, with a market capitalisation of 372.93M, and a P/E ratio of 100.0x.

Financial Highlights

Investment Breakdown

📈 Growth
Revenue and earnings growing steadily, indicating improving operating performance.
💰 Profitability
Adequate profitability with some margin variability in recent periods.
⚠️ Risk
Risk profile appears balanced versus broad market conditions.
💸 Valuation
Premium valuation reflects strong growth expectations already priced in.

OpenBook Logo Analysis

Reward: Moderate (58)

The scoring profile indicates moderate reward potential, with growth and profitability as the leading contributors. Risk indicators are elevated — volatility and macro sensitivity warrant consideration.

For informational purposes only. Not financial advice.

Company Information
SectorHealthcare
Market Cap372.93M
P/E Ratio100
Dividend YieldN/A
52 Week High2.1
52 Week Low1
Last AnnualJune
IPO DateN/A
IncorporatedUSA
Shares Outstanding373M
No. of Employees3,025
IndustryDiagnostics & Research
ExchangePINK
Beta0.166
CurrencyUSD · Reports in AUD